Obesity Clinical Trial
Official title:
The Effect of Breakfast Test Products on Acute Satiety Scores in Different Test Conditions
Rationale: The worldwide prevalence of obesity increases rapidly, and at the moment there
are more overweight than underweight people in the world. This is partly caused by increased
energy, or food intake. One of the physiological factors regulating the food intake pattern
is satiety. Though the regulation of food intake has been studied quite extensively, the
underlying mechanisms are not well elucidated yet and still new factors involved in this
regulation are being found. Therefore, in this study the investigators aim to develop an in
vitro screening tool combined with an in silico model for prediction of satiety, for cost-
and time - effective screening of satiating properties of new and existing complex food
products and (functional) ingredients, based on actual satiety scores measured. A second aim
of the Wholegrain Satiety project is to evaluate satiating properties of different types of
wholegrain breads and other oat based products, both for validation purposes and to
strengthen the scientific evidence for health benefits of wholegrain products. As part of
this study, acute satiety scores after consumption of various breakfast products in
well-controlled clinical conditions will be compared with satiety scores obtained in 'at
home' test conditions.
Objective: The current study aims to compare the acute satiety effect of carbohydrate
breakfast products.
In the present study the investigators will conduct a clinical trial in which a standard
protocol will be used to examine five different breakfasts (different in type: breakfast
cereals and bread, and macronutrient composition) with satiating ingredients which will
reveal actual human satiety scores. The visual analogue scales used for determination of
satiety feelings is an accepted method by EFSA and studied extensively. It is used by TNO in
an earlier carbohydrate containing breakfast experiment.
Subjects may feel and eat differently at home. Especially since supervision by a researcher
is known to influence behavior of participants. Self-measuring has the potential of giving
more reliable estimates of intervention effects. Therefore, it is interesting to repeat the
tests that are performed in the clinical unit, in an 'at home' condition, because that is
the place consumers eat their breakfast habitually (= ecological validity).
Study design: The study is designed as an open, randomized, controlled, cross-over trial.
Study population: Forty healthy, lean and overweight, non-restrained eating women.
Intervention: The intervention consists of five different normal breakfasts (normal amount,
about 243-355 kCal; bread, cooked oatmeal, cereal meal, fried egg with bread) provided as a
breakfast in the metabolic ward and at home.
Main study parameters/endpoints: Satiety scores will be obtained with visual analogue rating
scales (VAS). Subjects will rate hunger feelings, fullness feelings, satiety feelings,
desire to eat and rate their prospective food consumption, before and multiple times after
consumption of a breakfast. A test session lasts for four hours (t = 0, 15, 30, 45, 60, 90,
120, 150, 180, 210 and 240 minutes).
In the controlled conditions at TNO, finger pricks will be performed at t = 0, 30, 60, 90
and 120 minutes after breakfast consumption to measure blood glucose.
Nature and extent of the burden and risks associated with participation, benefit and group
relatedness: Subjects will consume prescribed, standardized breakfast products; five times
at a clinical unit and five times at home. No risk is associated with intake of the test
products. The VAS questionnaire will be filled in on the laptop multiple times on all test
days (at home and at the clinic). No risk or real burden is of concern in this study.
Subjects will perform finger pricks five times in each controlled session at TNO, what is
known as a minimally invasive technique to obtain drops of blood.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |